Global Cardiac Implant Devices Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027
- Published Date: 2021-04-23
- Report ID: 104733
- Pages: 125
-
Format:
Summary
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. Prudent Markets published a report for global Cardiac Implant Devices market in this environment.
In terms of revenue, this research report indicated that the global Cardiac Implant Devices market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Cardiac Implant Devices industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The Abbott Vascular Inc aims at producing XX K Units Cardiac Implant Devices in 2020, with XX % production to take place in global market, Medtronic accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Cardiac Implant Devices Market by Prudent Markets Include
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Cardiac Implant Devices Market
Abbott Vascular Inc
Medtronic
Biotronik
Bentley InnoMed GmbH
Elestim-Cardio
Cardioelectronica GmbH
Qualimed Innovative Medizinprodukte
Medico
Lepu Medical Technology
Boston Scientific Corporation
St.Jude Medical
Edwards Lifesciences Corporation
Biosensors International
Japan Lifeline
Sorin
JenaValve Technology
Opto Circuits
Hexacath
MicroPort Scientific
Cardionovum
Alvimedica
...
Major Type of Cardiac Implant Devices Covered in Prudent Markets report:
Implantable Cardiac Pacemakers (ICPs)
Implantable Cardioverter Defibrillators (ICD'S)
Cardiac Resynchronization Therapy Devices (CRT'S)
Coronary Stents
Others
Application Segments Covered in Prudent Markets Market
Myocardial Ischemia
Acute Myocardial Infarction
Arrhythmias
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Cardiac Implant Devices Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Implantable Cardiac Pacemakers (ICPs) -Product Introduction and Major Manufacturers
1.1.2 Implantable Cardioverter Defibrillators (ICD'S) -Product Introduction and Major Manufacturers
1.1.3 Cardiac Resynchronization Therapy Devices (CRT'S) -Product Introduction and Major Manufacturers
1.1.4 Coronary Stents -Product Introduction and Major Manufacturers
1.1.5 Others -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Cardiac Implant Devices Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027)
2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027)
3 Regional Market Analysis
3.1 China Cardiac Implant Devices Market
3.1.1 Top Companies leading Cardiac Implant Devices Development in China (2016-2021)
3.1.2 Sales Value of Major Company in China Market (2016-2021)
3.1.3 China Cardiac Implant Devices Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2026-2027)
3.2 EU Cardiac Implant Devices Market
3.2.1 Top Companies leading Cardiac Implant Devices Development in EU (2016-2021)
3.2.2 Sales Value of Major Company in EU Market (2016-2021)
3.2.3 EU Cardiac Implant Devices Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2026-2027)
3.3 USA Cardiac Implant Devices Market
3.3.1 Top Companies leading Cardiac Implant Devices Development in USA (2016-2021)
3.3.2 Sales Value of Major Company in USA Market (2016-2021)
3.3.3 USA Cardiac Implant Devices Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2026-2027)
3.4 Japan Cardiac Implant Devices Market
3.4.1 Top Companies leading Cardiac Implant Devices Development in Japan (2016-2021)
3.4.2 Sales Value of Major Company in Japan Market (2016-2021)
3.4.3 Japan Cardiac Implant Devices Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2026-2027)
3.5 India Cardiac Implant Devices Market
3.5.1 Top Companies leading Cardiac Implant Devices Development in India (2016-2021)
3.5.2 Sales Value of Major Company in India Market (2016-2021)
3.5.3 India Cardiac Implant Devices Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2026-2027)
3.6 Southeast Asia Cardiac Implant Devices Market
3.6.1 Top Companies leading Cardiac Implant Devices Development in Southeast Asia (2016-2021)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021)
3.6.3 Southeast Asia Cardiac Implant Devices Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2026-2027)
3.7 South America Cardiac Implant Devices Market
3.7.1 Top Companies leading Cardiac Implant Devices Development in South America (2016-2021)
3.7.2 Sales Value of Major Company in South America Market (2016-2021)
3.7.3 South America Cardiac Implant Devices Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2026-2027)
4 Value Chain (Impact of COVID-19)
4.1 Cardiac Implant Devices Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Cardiac Implant Devices Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2027)
5.1 Global Cardiac Implant Devices Sales and Growth Rate (2021-2027)
5.2 Global Cardiac Implant Devices Sales Value and Growth Rate (2021-2027)
6 Cardiac Implant Devices Competitive Analysis
6.1 Abbott Vascular Inc
6.1.1 Abbott Vascular Inc Company Profiles
6.1.2 Abbott Vascular Inc Product Introduction
6.1.3 Abbott Vascular Inc Cardiac Implant Devices Production, Revenue (2016-2021)
6.1.4 SWOT Analysis
6.2 Medtronic
6.2.1 Medtronic Company Profiles
6.2.2 Medtronic Product Introduction
6.2.3 Medtronic Cardiac Implant Devices Production, Revenue (2016-2021)
6.2.4 SWOT Analysis
6.3 Biotronik
6.3.1 Biotronik Company Profiles
6.3.2 Biotronik Product Introduction
6.3.3 Biotronik Cardiac Implant Devices Production, Revenue (2016-2021)
6.3.4 SWOT Analysis
6.4 Bentley InnoMed GmbH
6.4.1 Bentley InnoMed GmbH Company Profiles
6.4.2 Bentley InnoMed GmbH Product Introduction
6.4.3 Bentley InnoMed GmbH Cardiac Implant Devices Production, Revenue (2016-2021)
6.4.4 SWOT Analysis
6.5 Elestim-Cardio
6.5.1 Elestim-Cardio Company Profiles
6.5.2 Elestim-Cardio Product Introduction
6.5.3 Elestim-Cardio Cardiac Implant Devices Production, Revenue (2016-2021)
6.5.4 SWOT Analysis
6.6 Cardioelectronica GmbH
6.6.1 Cardioelectronica GmbH Company Profiles
6.6.2 Cardioelectronica GmbH Product Introduction
6.6.3 Cardioelectronica GmbH Cardiac Implant Devices Production, Revenue (2016-2021)
6.6.4 SWOT Analysis
6.7 Qualimed Innovative Medizinprodukte
6.7.1 Qualimed Innovative Medizinprodukte Company Profiles
6.7.2 Qualimed Innovative Medizinprodukte Product Introduction
6.7.3 Qualimed Innovative Medizinprodukte Cardiac Implant Devices Production, Revenue (2016-2021)
6.7.4 SWOT Analysis
6.8 Medico
6.8.1 Medico Company Profiles
6.8.2 Medico Product Introduction
6.8.3 Medico Cardiac Implant Devices Production, Revenue (2016-2021)
6.8.4 SWOT Analysis
6.9 Lepu Medical Technology
6.9.1 Lepu Medical Technology Company Profiles
6.9.2 Lepu Medical Technology Product Introduction
6.9.3 Lepu Medical Technology Cardiac Implant Devices Production, Revenue (2016-2021)
6.9.4 SWOT Analysis
6.10 Boston Scientific Corporation
6.10.1 Boston Scientific Corporation Company Profiles
6.10.2 Boston Scientific Corporation Product Introduction
6.10.3 Boston Scientific Corporation Cardiac Implant Devices Production, Revenue (2016-2021)
6.10.4 SWOT Analysis
6.11 St.Jude Medical
6.12 Edwards Lifesciences Corporation
6.13 Biosensors International
6.14 Japan Lifeline
6.15 Sorin
6.16 JenaValve Technology
6.17 Opto Circuits
6.18 Hexacath
6.19 MicroPort Scientific
6.20 Cardionovum
6.21 Alvimedica
7 Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
